Investors & Venture Capital Professionals
You need to validate the science. We provide independent technical due diligence that de-risks your biotech investments.
Venture Capital Firms
Technical Due Diligence · Investment Validation
Validate the scientific foundation of biotech investments with comprehensive technical due diligence and risk assessment.
Angel Investors
Scientific Validation · Risk Assessment
Get independent scientific validation to make informed investment decisions in early-stage biotech companies.
Investment Advisors
Due Diligence Support · Expert Analysis
Provide your clients with expert technical analysis and due diligence support for biotech investment opportunities.
Corporate Development
M&A Due Diligence · Technology Assessment
Evaluate potential acquisitions and partnerships with comprehensive technical due diligence and scientific validation.
Due diligence packages for every investment stage
From early screening to comprehensive M&A due diligence, we have the right package for your investment needs.
Start
Perfect for early-stage investment screening
- Scientific feasibility assessment
- Technology validation review
- Competitive landscape analysis
- Risk assessment report
- Investment recommendation
Grow
Ideal for Series A and growth stage investments
- Everything in Start, plus:
- Comprehensive due diligence report
- Market access & regulatory analysis
- IP landscape & patent review
- Clinical trial feasibility assessment
- Manufacturing & scalability analysis
- 30-day post-investment support
Scale
For large investments and M&A transactions
- Everything in Grow, plus:
- Full technical audit & validation
- International market assessment
- Regulatory pathway mapping
- Manufacturing & supply chain review
- Expert witness preparation
- Ongoing technical advisory (3 months)
Our method for validating biotech investments
A systematic approach for conducting comprehensive technical due diligence on biotech companies and technologies.
Assess
Review the scientific foundation, data quality, and technical feasibility of the biotech company or technology.
Evaluate the technology
Validate
Cross-reference company claims with published literature, expert opinions, and independent data sources.
Verify claims and data
Analyze
Assess competitive landscape, regulatory pathway, market potential, and scalability considerations.
Identify risks and opportunities
Report
Provide comprehensive due diligence report with clear recommendations, risk assessment, and investment guidance.
Deliver actionable insights
Client stories we love
What it's like to work with us, in our clients' words
"Able to translate scientific publications into blog post that are engaging and fun to read. People with no background in research will understand the subject matter."
"Emma was amazing."
"Profound knowledge and in-depth understanding of the neuroscience research field makes it easy to work and communicate with."
"Not only do they explain the current science, but they also offer valuable industry insights, giving readers a well-rounded understanding of the business side of biotech."
"They had the prowess to unpack the complexities of the biopharma and medical device industries."
"Helped out both strategically and in a hands-on capacity."
"She helped out both strategically and in a hands-on capacity. In addition to driving a great result, a variety of stakeholders LOVED Emma, and couldn't stop telling me how amazing she was. Get her on your team as soon as you have a chance!"